DOCSLIB.ORG

Chk1-Mediated Cdc25a Degradation As a Critical Mechanism for Normal Cell Cycle Progression Hidemasa Goto1,*, Toyoaki Natsume2,3, Masato T

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chk1-Mediated Cdc25a Degradation As a Critical Mechanism for Normal Cell Cycle Progression Hidemasa Goto1,*, Toyoaki Natsume2,3, Masato T © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs223123. doi:10.1242/jcs.223123 SHORT REPORT Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression Hidemasa Goto1,*, Toyoaki Natsume2,3, Masato T. Kanemaki2,3, Aika Kaito4, Shujie Wang1, Esteban C. Gabazza5, Masaki Inagaki4 and Akira Mizoguchi1 ABSTRACT ATM is primarily activated by DNA double-strand breaks Chk1 (encoded by CHEK1 in mammals) is an evolutionarily conserved (DSBs). ATM phosphorylates and activates Chk2. Both kinases TP53 protein kinase that transduces checkpoint signals from ATR to Cdc25A phosphorylate p53 (encoded by ) resulting in p53 stabilization, during the DNA damage response (DDR). In mammals, Chk1 also which promotes p21 (also known as CDKN1A) expression. p21 controls cellular proliferation even in the absence of exogenous DNA binds and inhibits the cyclin and cyclin-dependent kinase (CDK) damage. However, little is known about how Chk1 regulates complexes leading to cell cycle arrest. By contrast, ATR is activated unperturbed cell cycle progression, and how this effect under by a broader spectrum of DNA-damaging stimuli, such as ultraviolet physiological conditions differs from its regulatory role in DDR. Here, (UV) radiation, DNA replication stress and inter-strand DNA we have established near-diploid HCT116 cell lines containing crosslinking reagents. ATR phosphorylates and activates Chk1, endogenous Chk1 protein tagged with a minimum auxin-inducible which in turn phosphorylates and inhibits Cdc25 phosphatases. degron (mAID) through CRISPR/Cas9-based gene editing. Cdc25 dephosphorylates inhibitory phosphorylation sites on CDK Establishment of these cells enabled us to induce specific and rapid (e.g. CDK1-Tyr15), resulting in CDK activation. Thus, Cdc25 depletion of the endogenous Chk1 protein, which resulted in aberrant inhibition ends up causing cell cycle arrest (Boutros et al., 2007). – accumulation of DNA damage factors that induced cell cycle arrest at S There are three Cdc25 paralogs (Cdc25A Cdc25C) in human cells. or G2 phase. Cdc25A was stabilized upon Chk1 depletion before the Cdc25A phosphorylation by Chk1 triggers its degradation in a accumulation of DNA damage factors. Simultaneous depletion of Chk1 ubiquitin/proteasome-dependent manner (Boutros et al., 2007; and Cdc25A partially suppressed the defects caused by Chk1 single Mailand et al., 2000). Phosphorylation of Cdc25B and Cdc25C by depletion. These results indicate that, similar to its function in DDR, Chk1 reduces their phosphatase activity (Boutros et al., 2007). Chk1 controls normal cell cycle progression mainly by inducing DDR signaling pathways were initially considered to play critical Cdc25A degradation. roles mainly in cells under exogenous DNA-damaging stress. However, previous studies showing that complete deficiency of KEY WORDS: Chk1, Cdc25A, Auxin-inducible degron, AID, Cell cycle ATR or Chk1 leads to aberrant accumulation of DNA damage with progression early embryonic lethality (Brown and Baltimore, 2000; Liu et al., 2000; Takai et al., 2000) challenged this general belief. INTRODUCTION Interestingly, knockout of Cdc25A also results in early embryonic DNA damage caused by exogenous and endogenous factors occurs lethality (Ray et al., 2007). In sharp contrast, mice with complete constantly in normal cells. DNA lesion activates a variety of cellular deficiency of Cdc25B or Cdc25C alone or with double knockout of DNA damage response (DDR) mechanisms, including the cell cycle Cdc25B and Cdc25C are viable without any relevant phenotype, checkpoints, DNA repair, apoptosis and senescence (Bartek and except for some meiotic abnormalities during oogenesis in Cdc25B- Lukas, 2007; Ciccia and Elledge, 2010; Jackson and Bartek, 2009). knockout mice (Chen et al., 2001; Ferguson et al., 2005; Lincoln The DDR requires the activation of two evolutionarily conserved et al., 2002). Cells derived from Cdc25B and Cdc25C double- protein kinase cascades, the ATM–Chk2 and ATR–Chk1 (Chk1 and knockout mice show no apparent abnormalities in their cell cycle Chk2 are encoded by CHEK1 and CHEK2, respectively, in profile or DDR (Ferguson et al., 2005). However, in human somatic mammals) pathways (Antoni et al., 2007; Awasthi et al., 2015; cells, Cdc25B reportedly plays critical roles in normal G2/M Blackford and Jackson, 2017; Flynn and Zou, 2011; Goto et al., transition and in the cell cycle checkpoint at the G2 phase, together 2015; Medema and Macu˚rek, 2012; Reinhardt and Yaffe, 2009; with Cdc25A (Cazales et al., 2005; Lammer et al., 1998; Timofeev Saldivar et al., 2017; Shiloh and Ziv, 2013; Zhang and Hunter, 2014). et al., 2010; Vázquez-Novelle et al., 2010). A previous study has shown that Chk1 inhibition using a Chk1 1Department of Neural Regeneration and Cell Communication, Mie University inhibitor or Chk1-specific siRNA induces accumulation of DNA Graduate School of Medicine, Tsu, Mie 514-8507, Japan. 2Department of damage and DDR even in the absence of exogenous DNA insults Chromosome Science, National Institute of Genetics, Research Organization (Beck et al., 2010; Syljuasen et al., 2005). However, whether the of Information and Systems (ROIS), Mishima, Shizuoka 411-8540, Japan. 3Department of Genetics, The Graduate University for Advanced Studies signaling pathway mediated by Chk1 in unperturbed cell cycle (SOKENDAI), Mishima, Shizuoka 411-8540, Japan. 4Department of Physiology, Mie progression and in DDR is similar remains unknown. To clarify University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. 5Department of this, conditional gene-knockout- or RNA interference-mediated Immunology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. knockdown of Chk1 could be used. However, it takes days to observe significant phenotypic changes using these technical *Author for correspondence ([email protected]) approaches, and thus it is extremely difficult to distinguish H.G., 0000-0002-6796-4467 whether the observed phenotype is due to Chk1 inhibition or to DDR. The use of Chk1 inhibitor is an alternative approach but, in Received 23 July 2018; Accepted 2 January 2019 this case, specificity of the inhibitor could become a problem. To Journal of Cell Science 1 SHORT REPORT Journal of Cell Science (2019) 132, jcs223123. doi:10.1242/jcs.223123 overcome these difficulties, in the present study, we established a We examined the effect of acute Chk1 depletion on cell human colon carcinoma HCT116 cell line carrying endogenous proliferation in the absence of exogenous DNA insult. As shown Chk1 that can be rapidly and specifically degraded in an indole-3- in Fig. 2A, each Chk1–mAID cell line showed only marginal acetic acid (IAA; a natural auxin)-dependent manner (Natsume changes in cell growth after 1 day in the presence of IAA compared et al., 2016; Nishimura et al., 2009). Rapid Chk1 depletion impeded to control DMSO. However, a 3-day culture in the presence of IAA cell proliferation and caused accumulation of aberrant DNA damage significantly reduced the cell proliferation of four independent marker proteins, such as γH2AX (H2AX phosphorylated at Ser139; Chk1–mAID cell lines but not that of their parental cells (Fig. 2A; H2AX is encoded by H2AFX). Cdc25A stabilization was observed also see Fig. 3C). FACS analyses revealed that a 3-day culture in the before the accumulation of DNA damage factors. In addition, the presence of IAA increases the sub-G1 fraction (a measure of the Chk1 depletion-associated phenotype was partially suppressed by apoptotic cell fraction) in Chk1mACl/mACl cell lines (Fig. 2B). depletion of both Chk1 and Cdc25A, suggesting that Chk1 plays a However, as judged by the Trypan Blue staining, the percentage of role in the normal cell cycle in the absence of exogenous DNA dead cells varied from less than 2% to more than 10% by experiment damage mainly by targeting Cdc25A. (data not shown; also see FACS data in Fig. 4A), suggesting that the increase in apoptosis may not be the main cause of growth defect by RESULTS AND DISCUSSION Chk1 depletion. FACS analyses also indicated that the G2/M The CRISPR/Cas9 gene editing technology enables insertion of a fraction was elevated upon IAA treatment for 3 days in DNA fragment (e.g. tags and drug-resistant markers) at a desired Chk1mACl/mACl cells but not in their parental cells (Fig. 2B). Since gene locus by a sequence-specific DSB induction and homologous only 1–2% mitotic cells were detected in these IAA-treated cells recombination repair (Cong et al., 2013; Mali et al., 2013; Ran et al., (Fig. S2A), Chk1 depletion induces cell cycle arrest at the G2/M 2013). We combined this gene knock-in technology to generate transition; we observed a similar tendency for the Chk1mAM/mAM human conditional cells using a donor harboring a minimum auxin- cell lines (data not shown). A 3-day culture in the presence of IAA inducible degron (mAID) tag (Natsume and Kanemaki, 2017; increased the level of p53 and p21 proteins but not the level of Natsume et al., 2016; Nishimura et al., 2009). As shown in Fig. 1A–C, CDK1 phosphorylated at Tyr15 (an inactive form of CDK1; we established a human near-diploid HCT116 colon carcinoma cell Fig. S2B) in Chk1–mAID cell lines. Therefore, Chk1 depletion line (Thompson and Compton, 2008) expressing an auxin-inducible results in p53 stabilization, which induces cell cycle arrest likely ubiquitin ligase component, Oryza sativa (Os)TIR1, and the through the induction of CDK inhibitor(s), such as p21. endogenous Chk1 protein fused with mAID and a monomeric We analyzed early changes after IAA treatment by Clover (mAID–mClover; mACl) (Natsume et al., 2016) or with immunoblotting (Fig. 2C; Fig. S3). The phosphorylation of mAID fused to five repeats of the Myc epitope tag (mAID–5Myc; H2AX-Ser139 (γH2AX) and Chk2-Thr68 gradually increased mAM) at its C-terminus. We established two independent clones per after IAA incubation; it peaked at ∼20–24 h in the observed range each genotype. Even in the absence of IAA, the protein level of (from 0 h to 24 h).
Load more

Recommended publications
  • Analysis of the Stability of 70 Housekeeping Genes During Ips Reprogramming Yulia Panina1,2*, Arno Germond1 & Tomonobu M
    www.nature.com/scientificreports OPEN Analysis of the stability of 70 housekeeping genes during iPS reprogramming Yulia Panina1,2*, Arno Germond1 & Tomonobu M. Watanabe1 Studies on induced pluripotent stem (iPS) cells highly rely on the investigation of their gene expression which requires normalization by housekeeping genes. Whether the housekeeping genes are stable during the iPS reprogramming, a transition of cell state known to be associated with profound changes, has been overlooked. In this study we analyzed the expression patterns of the most comprehensive list to date of housekeeping genes during iPS reprogramming of a mouse neural stem cell line N31. Our results show that housekeeping genes’ expression fuctuates signifcantly during the iPS reprogramming. Clustering analysis shows that ribosomal genes’ expression is rising, while the expression of cell-specifc genes, such as vimentin (Vim) or elastin (Eln), is decreasing. To ensure the robustness of the obtained data, we performed a correlative analysis of the genes. Overall, all 70 genes analyzed changed the expression more than two-fold during the reprogramming. The scale of this analysis, that takes into account 70 previously known and newly suggested genes, allowed us to choose the most stable of all genes. We highlight the fact of fuctuation of housekeeping genes during iPS reprogramming, and propose that, to ensure robustness of qPCR experiments in iPS cells, housekeeping genes should be used together in combination, and with a prior testing in a specifc line used in each study. We suggest that the longest splice variants of Rpl13a, Rplp1 and Rps18 can be used as a starting point for such initial testing as the most stable candidates.
    [Show full text]
  • Cytokine-Driven Cell Cycling Is Mediated Through Cdc25a
    JCB: ARTICLE Cytokine-driven cell cycling is mediated through Cdc25A Annette R. Khaled,1,3 Dmitry V. Bulavin,2 Christina Kittipatarin,1 Wen Qing Li,3 Michelle Alvarez,1 Kyungjae Kim,3,5 Howard A. Young,4 Albert J. Fornace,2 and Scott K. Durum3 1University of Central Florida, BioMolecular Science Center, Orlando, FL 32628 2Division of Basic Sciences, National Cancer Institute, Bethesda, MD 20892 3Laboratory of Molecular Immunoregulation and 4Laboratory of Experimental Immunology, National Cancer Institute at Frederick, Frederick, MD 21702 5Department of Pharmacy, Sahm-Yook University, Seoul, Korea, 139-742 ymphocytes are the central mediators of the im- the critical mediator of proliferation. Withdrawal of IL-7 mune response, requiring cytokines for survival and or IL-3 from dependent lymphocytes activates the stress L proliferation. Survival signaling targets the Bcl-2 kinase, p38 MAPK, which phosphorylates Cdc25A, in- family of apoptotic mediators, however, the pathway for ducing its degradation. As a result, Cdk/cyclin com- the cytokine-driven proliferation of lymphocytes is poorly plexes remain phosphorylated and inactive and cells understood. Here we show that cytokine-induced cell arrest before the induction of apoptosis. Inhibiting p38 cycle progression is not solely dependent on the synthe- MAPK or expressing a mutant Cdc25A, in which the two sis of cyclin-dependent kinases (Cdks) or cyclins. Rather, p38 MAPK target sites, S75 and S123, are altered, ren- we observe that in lymphocyte cell lines dependent on ders cells resistant to cytokine withdrawal, restoring the interleukin-3 or interleukin-7, or primary lymphocytes activity of Cdk/cyclin complexes and driving the cell cycle dependent on interleukin 7, the phosphatase Cdc25A is independent of a growth stimulus.
    [Show full text]
  • 9. Atypical Dusps: 19 Phosphatases in Search of a Role
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital.CSIC Transworld Research Network 37/661 (2), Fort P.O. Trivandrum-695 023 Kerala, India Emerging Signaling Pathways in Tumor Biology, 2010: 185-208 ISBN: 978-81-7895-477-6 Editor: Pedro A. Lazo 9. Atypical DUSPs: 19 phosphatases in search of a role Yolanda Bayón and Andrés Alonso Instituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid c/ Sanz y Forés s/n, 47003 Valladolid, Spain Abstract. Atypical Dual Specificity Phosphatases (A-DUSPs) are a group of 19 phosphatases poorly characterized. They are included among the Class I Cys-based PTPs and contain the active site motif HCXXGXXR conserved in the Class I PTPs. These enzymes present a phosphatase domain similar to MKPs, but lack any substrate targeting domain similar to the CH2 present in this group. Although most of these phosphatases have no more than 250 amino acids, their size ranges from the 150 residues of the smallest A-DUSP, VHZ/DUSP23, to the 1158 residues of the putative PTP DUSP27. The substrates of this family include MAPK, but, in general terms, it does not look that MAPK are the general substrates for the whole group. In fact, other substrates have been described for some of these phosphatases, like the 5’CAP structure of mRNA, glycogen, or STATs and still the substrates of many A-DUSPs have not been identified. In addition to the PTP domain, most of these enzymes present no additional recognizable domains in their sequence, with the exception of CBM-20 in laforin, GTase in HCE1 and a Zn binding domain in DUSP12.
    [Show full text]
  • Review Article PTEN Gene: a Model for Genetic Diseases in Dermatology
    The Scientific World Journal Volume 2012, Article ID 252457, 8 pages The cientificWorldJOURNAL doi:10.1100/2012/252457 Review Article PTEN Gene: A Model for Genetic Diseases in Dermatology Corrado Romano1 and Carmelo Schepis2 1 Unit of Pediatrics and Medical Genetics, I.R.C.C.S. Associazione Oasi Maria Santissima, 94018 Troina, Italy 2 Unit of Dermatology, I.R.C.C.S. Associazione Oasi Maria Santissima, 94018 Troina, Italy Correspondence should be addressed to Carmelo Schepis, [email protected] Received 19 October 2011; Accepted 4 January 2012 Academic Editors: G. Vecchio and H. Zitzelsberger Copyright © 2012 C. Romano and C. Schepis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. PTEN gene is considered one of the most mutated tumor suppressor genes in human cancer, and it’s likely to become the first one in the near future. Since 1997, its involvement in tumor suppression has smoothly increased, up to the current importance. Germline mutations of PTEN cause the PTEN hamartoma tumor syndrome (PHTS), which include the past-called Cowden, Bannayan- Riley-Ruvalcaba, Proteus, Proteus-like, and Lhermitte-Duclos syndromes. Somatic mutations of PTEN have been observed in glioblastoma, prostate cancer, and brest cancer cell lines, quoting only the first tissues where the involvement has been proven. The negative regulation of cell interactions with the extracellular matrix could be the way PTEN phosphatase acts as a tumor suppressor. PTEN gene plays an essential role in human development. A recent model sees PTEN function as a stepwise gradation, which can be impaired not only by heterozygous mutations and homozygous losses, but also by other molecular mechanisms, such as transcriptional regression, epigenetic silencing, regulation by microRNAs, posttranslational modification, and aberrant localization.
    [Show full text]
  • Bioinformatics-Based Screening of Key Genes for Transformation of Liver
    Jiang et al. J Transl Med (2020) 18:40 https://doi.org/10.1186/s12967-020-02229-8 Journal of Translational Medicine RESEARCH Open Access Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma Chen Hao Jiang1,2, Xin Yuan1,2, Jiang Fen Li1,2, Yu Fang Xie1,2, An Zhi Zhang1,2, Xue Li Wang1,2, Lan Yang1,2, Chun Xia Liu1,2, Wei Hua Liang1,2, Li Juan Pang1,2, Hong Zou1,2, Xiao Bin Cui1,2, Xi Hua Shen1,2, Yan Qi1,2, Jin Fang Jiang1,2, Wen Yi Gu4, Feng Li1,2,3 and Jian Ming Hu1,2* Abstract Background: Hepatocellular carcinoma (HCC) is the most common type of liver tumour, and is closely related to liver cirrhosis. Previous studies have focussed on the pathogenesis of liver cirrhosis developing into HCC, but the molecular mechanism remains unclear. The aims of the present study were to identify key genes related to the transformation of cirrhosis into HCC, and explore the associated molecular mechanisms. Methods: GSE89377, GSE17548, GSE63898 and GSE54236 mRNA microarray datasets from Gene Expression Omni- bus (GEO) were analysed to obtain diferentially expressed genes (DEGs) between HCC and liver cirrhosis tissues, and network analysis of protein–protein interactions (PPIs) was carried out. String and Cytoscape were used to analyse modules and identify hub genes, Kaplan–Meier Plotter and Oncomine databases were used to explore relationships between hub genes and disease occurrence, development and prognosis of HCC, and the molecular mechanism of the main hub gene was probed using Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis.
    [Show full text]
  • The Regulatory Roles of Phosphatases in Cancer
    Oncogene (2014) 33, 939–953 & 2014 Macmillan Publishers Limited All rights reserved 0950-9232/14 www.nature.com/onc REVIEW The regulatory roles of phosphatases in cancer J Stebbing1, LC Lit1, H Zhang, RS Darrington, O Melaiu, B Rudraraju and G Giamas The relevance of potentially reversible post-translational modifications required for controlling cellular processes in cancer is one of the most thriving arenas of cellular and molecular biology. Any alteration in the balanced equilibrium between kinases and phosphatases may result in development and progression of various diseases, including different types of cancer, though phosphatases are relatively under-studied. Loss of phosphatases such as PTEN (phosphatase and tensin homologue deleted on chromosome 10), a known tumour suppressor, across tumour types lends credence to the development of phosphatidylinositol 3--kinase inhibitors alongside the use of phosphatase expression as a biomarker, though phase 3 trial data are lacking. In this review, we give an updated report on phosphatase dysregulation linked to organ-specific malignancies. Oncogene (2014) 33, 939–953; doi:10.1038/onc.2013.80; published online 18 March 2013 Keywords: cancer; phosphatases; solid tumours GASTROINTESTINAL MALIGNANCIES abs in sera were significantly associated with poor survival in Oesophageal cancer advanced ESCC, suggesting that they may have a clinical utility in Loss of PTEN (phosphatase and tensin homologue deleted on ESCC screening and diagnosis.5 chromosome 10) expression in oesophageal cancer is frequent, Cao et al.6 investigated the role of protein tyrosine phosphatase, among other gene alterations characterizing this disease. Zhou non-receptor type 12 (PTPN12) in ESCC and showed that PTPN12 et al.1 found that overexpression of PTEN suppresses growth and protein expression is higher in normal para-cancerous tissues than induces apoptosis in oesophageal cancer cell lines, through in 20 ESCC tissues.
    [Show full text]
  • Supplementary Material
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Page 1 / 45 SUPPLEMENTARY MATERIAL Appendix A1: Neuropsychological protocol. Appendix A2: Description of the four cases at the transitional stage. Table A1: Clinical status and center proportion in each batch. Table A2: Complete output from EdgeR. Table A3: List of the putative target genes. Table A4: Complete output from DIANA-miRPath v.3. Table A5: Comparison of studies investigating miRNAs from brain samples. Figure A1: Stratified nested cross-validation. Figure A2: Expression heatmap of miRNA signature. Figure A3: Bootstrapped ROC AUC scores. Figure A4: ROC AUC scores with 100 different fold splits. Figure A5: Presymptomatic subjects probability scores. Figure A6: Heatmap of the level of enrichment in KEGG pathways. Kmetzsch V, et al. J Neurol Neurosurg Psychiatry 2021; 92:485–493. doi: 10.1136/jnnp-2020-324647 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Appendix A1. Neuropsychological protocol The PREV-DEMALS cognitive evaluation included standardized neuropsychological tests to investigate all cognitive domains, and in particular frontal lobe functions. The scores were provided previously (Bertrand et al., 2018). Briefly, global cognitive efficiency was evaluated by means of Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS). Frontal executive functions were assessed with Frontal Assessment Battery (FAB), forward and backward digit spans, Trail Making Test part A and B (TMT-A and TMT-B), Wisconsin Card Sorting Test (WCST), and Symbol-Digit Modalities test.
    [Show full text]
  • Human Phosphatase CDC14A Regulates Actin Organization Through Dephosphorylation of Epithelial Protein Lost in Neoplasm
    Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm Nan-Peng Chena,b, Borhan Uddina,b, Robert Hardta, Wen Dinga, Marko Panica,b, Ilaria Lucibelloa, Patricia Kammererc, Thomas Rupperta, and Elmar Schiebela,1 aZentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Deutsches Krebsforschungszentrum (DKFZ)–ZMBH Allianz, Universität Heidelberg, 69120 Heidelberg, Germany; bHartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS), Universität Heidelberg, 69120 Heidelberg, Germany; and cMax Planck Institute of Biochemistry, 82152 Martinsried, Germany Edited by Thomas D. Pollard, Yale University, New Haven, CT, and approved April 11, 2017 (received for review November 24, 2016) CDC14 is an essential dual-specificity phosphatase that counteracts Because there have been no systematic attempts to identify CDK1 activity during anaphase to promote mitotic exit in Saccharo- phospho-sites that are regulated by hCDC14A, we know relatively myces cerevisiae. Surprisingly, human CDC14A is not essential for little about the identity of either the proteins that are dephos- cell cycle progression. Instead, it regulates cell migration and cell phorylated by hCDC14A or, indeed, the kinases that counteract adhesion. Little is known about the substrates of hCDC14A and hCDC14A in human cells. The only known substrate of hCDC14A the counteracting kinases. Here, we combine phospho-proteome that acts within the actin cytoskeleton is the protein Kibra (20, 21). profiling and proximity-dependent biotin identification to identify However, considering the broad distribution of hCDC14A hCDC14A substrates. Among these targets were actin regulators, throughout the actin network, it is highly likely that hCDC14A including the tumor suppressor eplin. hCDC14A counteracts EGF- dephosphorylates additional actin-associated proteins.
    [Show full text]
  • Cyclex Protein Phosphatase Cdc25a Fluorometric Assay Kit 100 Assays Cat# CY-1352
    Protein Phosphatase Cdc25A Fluorometric Assay Kit User’s Manual For Research Use Only, Not for use in diagnostic procedures Fluorometric Assay Kit for Measuring Cdc25A Phosphatase Activity CycLex Protein Phosphatase Cdc25A Fluorometric Assay Kit 100 Assays Cat# CY-1352 Intended Use............................................ 1 Storage..................................................... 1 Introduction ............................................. 2 Principle of the Assay.............................. 2 Materials Provided .................................. 3 Materials Required but not Provided.….. 3 Precautions and Recommendations......... 3-4 Detailed Protocol..................................... 4-6 Evaluation of Results .............................. 7-9 Troubleshooting ...................................... 10 Reagent Stability ..................................... 10 References................................................ 11 Related Products.......................................11-12 Intended Use The MBL Research product Protein Phosphatase Cdc25A Fluorometric Assay Kit is a fluorometric and non-radioactive assay designed to measure the activity of Cdc25A protein phosphatase. This 96-well assay is useful for screening inhibitors and modulators of Cdc25A activity in HTS. The kit includes all necessary components, including recombinant, human Cdc25A (catalytic domain), for use in preinvestigational drug discovery assays. This assay kit is for research use only and not for use in human, diagnostic, or therapeutic procedures. Storage
    [Show full text]
  • Genetic Alterations of Protein Tyrosine Phosphatases in Human Cancers
    Oncogene (2015) 34, 3885–3894 © 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15 www.nature.com/onc REVIEW Genetic alterations of protein tyrosine phosphatases in human cancers S Zhao1,2,3, D Sedwick3,4 and Z Wang2,3 Protein tyrosine phosphatases (PTPs) are enzymes that remove phosphate from tyrosine residues in proteins. Recent whole-exome sequencing of human cancer genomes reveals that many PTPs are frequently mutated in a variety of cancers. Among these mutated PTPs, PTP receptor T (PTPRT) appears to be the most frequently mutated PTP in human cancers. Beside PTPN11, which functions as an oncogene in leukemia, genetic and functional studies indicate that most of mutant PTPs are tumor suppressor genes. Identification of the substrates and corresponding kinases of the mutant PTPs may provide novel therapeutic targets for cancers harboring these mutant PTPs. Oncogene (2015) 34, 3885–3894; doi:10.1038/onc.2014.326; published online 29 September 2014 INTRODUCTION tyrosine/threonine-specific phosphatases. (4) Class IV PTPs include Protein tyrosine phosphorylation has a critical role in virtually all four Drosophila Eya homologs (Eya1, Eya2, Eya3 and Eya4), which human cellular processes that are involved in oncogenesis.1 can dephosphorylate both tyrosine and serine residues. Protein tyrosine phosphorylation is coordinately regulated by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases 1 THE THREE-DIMENSIONAL STRUCTURE AND CATALYTIC (PTPs). Although PTKs add phosphate to tyrosine residues in MECHANISM OF PTPS proteins, PTPs remove it. Many PTKs are well-documented oncogenes.1 Recent cancer genomic studies provided compelling The three-dimensional structures of the catalytic domains of evidence that many PTPs function as tumor suppressor genes, classical PTPs (RPTPs and non-RPTPs) are extremely well because a majority of PTP mutations that have been identified in conserved.5 Even the catalytic domain structures of the dual- human cancers are loss-of-function mutations.
    [Show full text]
  • Purification and Characterization of Two Members of the Protein
    PURIFICATION AND CHARACTERIZATION OF TWO MEMBERS OF THE PROTEIN TYROSINE PHOSPHATASE FAMILY: DUAL SPECIFICITY PHOSPHATASE PVP AND LOW MOLECULAR WEIGHT PHOSPHATASE WZB By Paula A. Livingston A Thesis Submitted to the Faculty of The Charles E. Schmidt College of Science in Partial Fulfillment for the Degree of Master of Science Florida Atlantic University Boca Raton, Florida December 2009 i ACKNOWLEDGMENTS The author wishes to thank her thesis advisor, Dr. Stefan Vetter, and the members of her committee, Dr. Estelle Leclerc and Dr. Predrag Cudic, for their advice and support throughout her years at Florida Atlantic University. The author also wishes to thank her family for their unending support and encouragement without which this would not have been possible. The author would also like to thank her nephew and niece, Griffin and Skye, for inspiring her throughout her entire graduate experience. iii ABSTRACT Author: Paula A. Livingston Title: Purification and Characterization of Two Members of the Protein Tyrosine Phosphatase Family: Dual Specificity Phosphatase PVP and Low Molecular Weight Phosphatase WZB Institution: Florida Atlantic University Thesis Advisor: Dr. Stefan W. Vetter Degree: Master of Science Year: 2009 Two protein tyrosine phosphatases, dual specificity phosphatase PVP and low molecular weight phosphatase WZB were purified and characterized. PVP was expressed as inclusion bodies and a suitable purification and refolding method was devised. Enzyme kinetics revealed that p-nitrophenylphosphate and β-naphthyl phosphate were substrates with KM of 4.0mM and 8.1mM respectively. PVP showed no reactivity towards phosphoserine. Kinetic characterization of WZB showed that only p- nitrophenylphosphate was a substrate with no affinity for β-naphthyl phosphate and phosphoserine.
    [Show full text]
  • Lenalidomide Induces Cell Death in an MDS-Derived Cell Line with Deletion of Chromosome 5Q by Inhibition of Cytokinesis
    Leukemia (2010) 24, 748–755 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis A Matsuoka1, A Tochigi1, M Kishimoto1, T Nakahara1, T Kondo1, T Tsujioka1, T Tasaka1, Y Tohyama2 and K Tohyama1 1Department of Laboratory Medicine, Kawasaki Medical School, Okayama, Japan; and 2Division of Biochemistry, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Hyogo, Japan Myelodysplastic syndromes (MDS) are a group of hematopoietic higher-risk groups with del(5q) that are susceptible to leukemic stem cell disorders characterized by refractory cytopenias transformation.6 Several hematopoiesis-related genes and tumor and susceptibility to leukemic transformation. On a subset of suppressor genes are located at 5q locus, and SPARC,7 MDS patients with deletion of the long arm of chromosome5 8 9 10 11 (del(5q)), lenalidomide exerts hematological and cytogenetic CTNNA1, EGR1, RPS14 and CDC25C are reported as effects, but the underlying pharmacological mechanisms are the candidate genes of MDS with del(5q) or 5q- syndrome. not fully understood. In this study, we have investigated the Lenalidomide, a derivative of thalidomide, is shown to in vitro effects of lenalidomide on an MDS-derived cell line, exert plenty of biological actions including inhibition of MDS-L, which carries del(5q) and complex chromosome angiogenesis,12 suppression of proinflammatory cytokine abnormalities. We found that the growth of MDS-L cells was production such as TNF-a,13 enhancement of T- and NK-cell specifically suppressed mainly by apoptosis, and in addition, 14–16 multinucleated cells were frequently formed and finally died activation.
    [Show full text]